Publications by authors named "Stanley Ly"

Claim this Profile
T
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax.
Anudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly, Bin Yuan, Fouad El-Dana

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML.
Anudishi Tyagi, Stanley Ly, Fouad El-Dana, Bin Yuan, Appalaraju Jaggupilli

Blood· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic stress induces GD2 cancer stem cell-like phenotype in triple-negative breast cancer.
Appalaraju Jaggupilli, Stanley Ly, Khoa Nguyen, Vivek Anand, Bin Yuan

Br J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2 breast cancer stem-like cells.
Stanley Ly, Vivek Anand, Fouad El-Dana, Khoa Nguyen, Yiming Cai

J Immunother Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.
Bin Yuan, Fouad El Dana, Stanley Ly, Yuanqing Yan, Vivian Ruvolo

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis